Delano Ladd Sells 6,000 Shares of HealthEquity (NASDAQ:HQY) Stock

Key Points

• Delano Ladd, EVP of HealthEquity, sold 6,000 shares of the company's stock for approximately $564,660, reducing his ownership by 7.02% to 79,456 shares.
• HealthEquity's stock increased by 2.4%, reaching a trading price of $95.97, with a market capitalization of $8.27 billion.
• Analyst ratings are generally positive, with a consensus target price of $119.77 and multiple firms upgrading their ratings to "Buy" or higher for HealthEquity stock.

HealthEquity, Inc. (NASDAQ:HQY - Get Free Report) EVP Delano Ladd sold 6,000 shares of the company's stock in a transaction on Friday, September 19th. The shares were sold at an average price of $94.11, for a total value of $564,660.00. Following the completion of the transaction, the executive vice president owned 79,456 shares of the company's stock, valued at $7,477,604.16. The trade was a 7.02% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link.

HealthEquity Trading Down 1.0%

HealthEquity stock traded down $0.92 during trading on Tuesday, hitting $95.06. The company's stock had a trading volume of 423,016 shares, compared to its average volume of 1,036,085. The stock's fifty day moving average is $92.82 and its 200 day moving average is $93.91. HealthEquity, Inc. has a 1-year low of $74.07 and a 1-year high of $116.65. The company has a debt-to-equity ratio of 0.47, a quick ratio of 4.23 and a current ratio of 4.23. The stock has a market capitalization of $8.19 billion, a price-to-earnings ratio of 57.61, a P/E/G ratio of 1.34 and a beta of 0.50.

Wall Street Analyst Weigh In

A number of equities research analysts have issued reports on HQY shares. JMP Securities boosted their price target on HealthEquity from $110.00 to $117.00 and gave the company a "market outperform" rating in a research report on Wednesday, June 4th. Deutsche Bank Aktiengesellschaft upped their target price on HealthEquity from $98.00 to $115.00 and gave the stock a "buy" rating in a research report on Thursday, June 5th. Royal Bank Of Canada upped their target price on HealthEquity from $109.00 to $110.00 and gave the stock an "outperform" rating in a research report on Wednesday, September 3rd. JPMorgan Chase & Co. upped their target price on HealthEquity from $125.00 to $126.00 and gave the stock an "overweight" rating in a research report on Wednesday, September 3rd. Finally, Raymond James Financial reaffirmed a "strong-buy" rating and issued a $120.00 target price (up previously from $115.00) on shares of HealthEquity in a research report on Tuesday, July 8th. One investment analyst has rated the stock with a Strong Buy rating, eleven have assigned a Buy rating and one has assigned a Hold rating to the company's stock. According to MarketBeat, the stock presently has a consensus rating of "Buy" and a consensus price target of $119.77.

Hedge Funds Weigh In On HealthEquity

A number of hedge funds have recently added to or reduced their stakes in the business. Invesco Ltd. boosted its holdings in HealthEquity by 50.6% in the first quarter. Invesco Ltd. now owns 2,446,198 shares of the company's stock worth $216,171,000 after purchasing an additional 821,425 shares during the period. Westfield Capital Management Co. LP raised its position in shares of HealthEquity by 124.6% during the 2nd quarter. Westfield Capital Management Co. LP now owns 1,265,208 shares of the company's stock worth $132,543,000 after purchasing an additional 701,819 shares during the period. Goldman Sachs Group Inc. raised its position in shares of HealthEquity by 1.4% during the 1st quarter. Goldman Sachs Group Inc. now owns 1,133,166 shares of the company's stock worth $100,138,000 after purchasing an additional 15,458 shares during the period. Charles Schwab Investment Management Inc. raised its position in shares of HealthEquity by 2.6% during the 2nd quarter. Charles Schwab Investment Management Inc. now owns 1,129,115 shares of the company's stock worth $118,286,000 after purchasing an additional 28,145 shares during the period. Finally, Geneva Capital Management LLC raised its position in shares of HealthEquity by 6.2% during the 2nd quarter. Geneva Capital Management LLC now owns 1,108,241 shares of the company's stock worth $116,099,000 after purchasing an additional 64,487 shares during the period. Institutional investors and hedge funds own 99.55% of the company's stock.

About HealthEquity

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.